Dr. Jeffrey Morgan Named Division Chief

Jeffrey Morgan appointed (320x240)
Jeffrey Morgan, M.D.

Jeffrey A. Morgan, M.D., joins the Michael E. DeBakey Department of Surgery as the newly appointed chief of the Division of Cardiothoracic Transplantation and Circulatory Support and surgical director of the Advanced Heart Failure Center of Excellence at Baylor College of Medicine.

Dr. Morgan specializes in treating patients with advanced heart and/or lung failure. Dr. Morgan implants mechanical circulatory support devices for left ventricular, right ventricular, or biventricular failure as a bridge to transplant (BTT) or destination therapy (DT). This includes left ventricular assist devices (LVADs), such as the HeartMate II, HeartMate III, and HeartWare HVAD, as well as the SynCardia Total Artificial Heart (TAH).

Dr. Morgan completed his General Surgery Residency at Mount Sinai Medical Center in New York and his Cardiothoracic Surgery Residency at New York University. He went on to complete fellowship training in cardiac transplantation and mechanical circulatory support at Columbia Presbyterian Medical Center.

Dr. Morgan comes to Houston by way of Michigan where he previously held a position as associate professor at Wayne State University School of Medicine.  He served as surgical director for Mechanical Circulatory Support and associate director for Heart and Lung Transplantation at Henry Ford Hospital in Detroit.

Dr. Morgan’s research is focused on advanced heart failure with numerous publications, national and international presentations, and book chapters. He is the section editor for Adult Mechanical Circulatory Support for the American Society of Artificial Internal Organs (ASAIO) Journal and is on the Editorial Board of The Journal of Heart and Lung Transplantation. He is also a reviewer for several other journals including The Annals of Thoracic Surgery and the Journal of the American College of Cardiology. Dr. Morgan served on the ISHLT Standards and Guidelines Committee and was a Task Force chair for the ISHLT Guidelines for MCS. He is also a previous chair of the Cardiac Track Programming Committee for the ASAIO Annual Conference. Dr. Morgan has moderated numerous sessions on mechanical support and transplant at ASAIO, ISHLT, and the American College of Cardiology.

Dr. Morgan is passionate about improving outcomes in patients with advanced heart or lung failure. He has participated in numerous clinical trials including Thoratec’s HeartMate II BTT and DT trials, HeartWare’s HVAD BTT and DT trials, the HeartMate III trial, and SynCardia’s 50 cc TAH trial. Dr. Morgan is also investigating the utility of stem cells as an adjunct measure for myocardial recovery, as part of the LVAD MPC II trial.